血浆代谢组学识别与分层糖耐量受损患者
该研究基于波美拉尼亚健康研究827名无糖尿病参与者的血浆样本,采用质谱和质子核磁共振代谢组学检测,发现99种代谢物和22项脂蛋白指标与OGTT 2小时血糖或胰岛素显著相关,并据此将159例IGT患者分为两个代谢亚组;结合临床与代谢组学特征的IGT预测模型AUC为0.84。
要点
- 99种代谢物和22项脂蛋白指标与OGTT 2小时血糖或胰岛素显著相关。
- IGT患者经无监督聚类可分为两个代谢特征不同的亚组。
- 临床联合代谢组学特征的IGT预测模型AUC为0.84。
核心结论
- 代谢组学方法揭示了与OGTT反应及IGT直接相关的分子特征,并显示IGT患者存在可区分的代谢亚群。
研究设计与样本
- 研究纳入波美拉尼亚健康研究中827名无糖尿病的参与者,采用质谱和质子核磁共振光谱检测血浆样本。
主要发现
- 共99种代谢物和22项脂蛋白指标与2小时血糖或2小时胰岛素水平显著相关。
- 相关代谢物包括支链氨基酸酮酸、酰基肉碱、溶血磷脂或磷脂酰胆碱的基线浓度变异。
- 159例IGT患者经k-means无监督聚类分为两个 distinct 代谢组。
- 结合临床与代谢组学特征的IGT预测模型AUC为0.84,较基于既定临床指标的预测略有改善。
临床怎么用
- 代谢组学特征可能辅助识别IGT并对其进行代谢分层,但尚需进一步验证后用于临床。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Impaired glucose tolerance (IGT) is one of the presymptomatic states of type 2 diabetes mellitus and requires an oral glucose tolerance test (OGTT) for diagnosis. Our aims were twofold: (i) characterize signatures of small molecules predicting the OGTT response and (ii) identify metabolic subgroups of participants with IGT. METHODS: Plasma samples from 827 participants of the Study of Health in Pomerania free of diabetes were measured using mass spectrometry and proton-nuclear magnetic resonance spectroscopy. Linear regression analyses were used to screen for metabolites significantly associated with the OGTT response after 2 hours, adjusting for baseline glucose and insulin levels as well as important confounders. A signature predictive for IGT was established using regularized logistic regression. All cases with IGT (N = 159) were selected and subjected to unsupervised clustering using a k-means approach. RESULTS AND CONCLUSION: In total, 99 metabolites and 22 lipoprotein measures were significantly associated with either 2-hour glucose or 2-hour insulin levels. Those comprised variations in baseline concentrations of branched-chain amino ketoacids, acylcarnitines, lysophospholipids, or phosphatidylcholines, largely confirming previous studies. By the use of these metabolites, subjects with IGT segregated into two distinct groups. Our IGT prediction model combining both clinical and metabolomics traits achieved an area under the curve of 0.84, slightly improving the prediction based on established clinical measures. The present metabolomics approach revealed molecular signatures associated directly to the response of the OGTT and to IGT in line with previous studies. However, clustering of subjects with IGT revealed distinct metabolic signatures of otherwise similar individuals, pointing toward the possibility of metabolomics for patient stratification.
引用
- Wildberg C, Masuch A, Budde K, et al. Plasma Metabolomics to Identify and Stratify Patients With Impaired Glucose Tolerance. J Clin Endocrinol Metab. 2019. PMID: 31390012. doi:10.1210/jc.2019-01104
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。